Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration

Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration

Lihua chen,1,2,&ast; Yuxuan Huang,3,4,&ast; Binhua Dong,3,4 Yu Gu,1,2 Ye Li,3,4 Wei Cang,1,2 Pengming Sun,3,4 Yang Xiang1,2 1Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People’s Re...

Full description

Bibliographic Details
Main Authors:	chen L, Huang Y, Dong B, Gu Y, Li Y, Cang W, Sun P, Xiang Y
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-10-01
Series:	Journal of Inflammation Research
Subjects:	flt3lg cervical cancer prognosis tumor-infiltration immune cells immunotherapy
Online Access:	https://www.dovepress.com/low-level-flt3lg-is-a-novel-poor-prognostic-biomarker-for-cervical-can-peer-reviewed-fulltext-article-JIR

Similar Items

High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancer
by: Rui Chen, et al.
Published: (2022-09-01)

Mutated Flt3Lg Provides Reduced Flt3 Recycling Compared to Wild-Type Flt3Lg and Retains the Specificity of Flt3Lg-Based CAR T-Cell Targeting in AML Models
by: Varvara Maiorova, et al.
Published: (2023-04-01)

INHBA is a Prognostic Biomarker and Correlated With Immune Cell Infiltration in Cervical Cancer
by: Kaidi Zhao, et al.
Published: (2022-01-01)

The Flt3L/Flt3 Axis in Dendritic Cell Biology and Cancer Immunotherapy
by: Francisco J. Cueto, et al.
Published: (2021-03-01)

FLT3LG and IFITM3P6 consolidate T cell activity in the bone marrow microenvironment and are prognostic factors in acute myelocytic leukemia
by: Haiyan Chen, et al.
Published: (2022-08-01)

Lymph node metastasis-related gene signature shows good performance in predicting prognosis and immune infiltration in cervical cancer
by: Yilin Guo, et al.
Published: (2023-06-01)

PSGL-1 is a novel tumor microenvironment prognostic biomarker with cervical high-grade squamous lesions and more
by: Yingying Lin, et al.
Published: (2023-03-01)

Role of Biomarkers in FLT3 AML
by: Nitika, et al.
Published: (2022-02-01)

FLT3LG - a biomarker reflecting clinical responses to the immunogenic cell death inducer oxaliplatin
by: Jonathan G. Pol, et al.
Published: (2020-01-01)

Comprehensive bioinformatics analysis of the expression, prognostic value, and immune infiltration of chromobox family members in cervical cancer
by: Dan Liao, et al.
Published: (2023-04-01)

Gelsolin Can Be a Prognostic Biomarker and Correlated with Immune Infiltrates in Gastric Cancer
by: Wu Y, et al.
Published: (2022-01-01)

Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma
by: Fang Wen, et al.
Published: (2021-11-01)

FLT3 - ITD positive acute lymphocytic leukemia, does it impact on disease´s course?
by: Sebastian Kobold, et al.
Published: (2010-06-01)

Significance of Immunogenic Cell Death-Related Prognostic Gene Signature in Cervical Cancer Prognosis and Anti-Tumor Immunity
by: Jiang S, et al.
Published: (2023-05-01)

Leucyl and Cystinyl Aminopeptidase as a Prognostic-Related Biomarker in OV Correlating with Immune Infiltrates
by: Ma Q, et al.
Published: (2023-06-01)

FLT3 Mutation as a Significant Prognostic Marker in de novo Acute Myeloid Leukemia Patients: Incidence, Distribution and Association with Cytogenetic Findings in a Study from South India
by: Santhi Sarojam, et al.
Published: (2014-10-01)

UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma
by: Li D, et al.
Published: (2021-10-01)

ADCY7 mRNA Is a Novel Biomarker in HPV Infection and Cervical High-Grade Squamous Lesions or Higher
by: Lihua Chen, et al.
Published: (2023-03-01)

Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells
by: Ying Wang, et al.
Published: (2018-05-01)

KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma
by: Sun Z, et al.
Published: (2023-10-01)

SIRT7 is a Prognostic Biomarker in Kidney Renal Clear Cell Carcinoma That is Correlated with Immune Cell Infiltration
by: Zhang W, et al.
Published: (2022-03-01)

GABRP is a Promising Prognostic Biomarker and Associated with Immune Cell Infiltration in Lung Squamous Cell Carcinoma
by: Fu J, et al.
Published: (2023-04-01)

PCOLCE Is Potent Prognostic Biomarker and Associates With Immune Infiltration in Gastric Cancer
by: Aizhai Xiang, et al.
Published: (2020-12-01)

MELK is a prognostic biomarker and correlated with immune infiltration in glioma
by: Haiyan Yang, et al.
Published: (2022-10-01)

PODN is a prognostic biomarker and correlated with immune infiltrates in osteosarcoma
by: Feng Yao, et al.
Published: (2021-07-01)

DNA Damage Repair-Related Genes Signature for Immune Infiltration and Outcome in Cervical Cancer
by: Xinghao Wang, et al.
Published: (2022-03-01)

“FLipping” the Story: FLT3-Mutated Acute Myeloid Leukemia and the Evolving Role of FLT3 Inhibitors
by: Tristan E. Knight, et al.
Published: (2022-07-01)

Characterization of the Immune Cell Infiltration Landscape Uncovers Prognostic and Immunogenic Characteristics in Lung Adenocarcinoma
by: Xin Wang, et al.
Published: (2022-05-01)

CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma
by: Feng Wang, et al.
Published: (2022-07-01)

FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies
by: Vanessa E. Kennedy, et al.
Published: (2020-12-01)

Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma
by: Lili Guo, et al.
Published: (2022-08-01)

FLT3-TKD in the prognosis of patients with acute myeloid leukemia: A meta-analysis
by: Shuping Li, et al.
Published: (2023-02-01)

SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma
by: Huayi Feng, et al.
Published: (2022-12-01)

Identification of a coagulation‐related signature correlated with immune infiltration and their prognostic implications in lung adenocarcinoma
by: Siqian Yang, et al.
Published: (2023-11-01)

Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma
by: Deng Z, et al.
Published: (2021-12-01)

AGTRAP Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
by: Shanshan Liu, et al.
Published: (2021-09-01)

Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma
by: Changyu Zhu, et al.
Published: (2022-01-01)

Discovery of 5-methyl-N-(2-arylquinazolin-7-yl)isoxazole-4-carboxamide analogues as highly selective FLT3 inhibitors
by: Daseul Im, et al.
Published: (2020-01-01)

TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma
by: Haining Li, et al.
Published: (2022-03-01)

A Review of FLT3 Kinase Inhibitors in AML
by: Cristina Negotei, et al.
Published: (2023-10-01)